| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $70.4M | +18.6% |
| Cost of Revenue | $9.3M | -42.7% |
| R&D Expense | $52.3M | +13.1% |
| SG&A Expense | $47.1M | -14.6% |
| Operating Income | -$41.7M | +28.7% |
| Pre-tax Income | -$43.9M | +32.7% |
| Income Tax | $47K | +38.2% |
| Net Income | -$44.0M | +32.6% |
| EPS (Basic) | -$0.50 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $50.8M | +163.7% |
| Short-term Investments | $27.4M | -49.4% |
| Inventory | $1.8M | +1.0% |
| Current Assets | $96.8M | -2.0% |
| Total Assets | $147.8M | -0.8% |
| Current Liabilities | $25.3M | +7.1% |
| Long-term Debt | $40.1M | +38.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.4M | +60.8% |
| Capital Expenditures | $4.5M | +3.9% |
| Investing Cash Flow | $23.5M | +141.2% |
| Financing Cash Flow | $27.9M | -53.9% |
| Free Cash Flow | -$23.8M | +55.6% |
| +43.8% |
| EPS (Diluted) | -$0.50 | +43.8% |
| Total Liabilities |
| $97.3M |
| +18.5% |
| Stockholders' Equity | $50.5M | -24.5% |